EP2685986
GLUCOSYLCERAMIDE SYNTHASE INHIBITOR
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
16.3.2012EP published:
27.11.2019EP application number:
12760259.7
EPO information:
European Patent Register
Max expiry date:
15.3.2032Expiry date:
15.3.2021
Title:
GLUCOSYLCERAMIDE SYNTHASE INHIBITOR
Timeline
Today
16.3.2012EP application
27.11.2019EP Publication
15.3.2021Expires
Owner
Name:
Genzyme CorporationAddress:
50 Binney Street, 02142, Cambridge, MA, US
Inventor
Name:
BOURQUE, ElyseAddress:
Waltham, MA, US
Name:
CELATKA, CassandraAddress:
Waltham, MA, US
Name:
HIRTH, BradfordAddress:
Waltham, MA, US
Name:
METZ, MarkusAddress:
Waltham, MA, US
Name:
ZHAO, ZhongAddress:
Waltham, MA, US
Name:
SKERLJ, RenatoAddress:
Waltham, MA, US
Name:
XIANG, YibinAddress:
Waltham, MA, US
Name:
JANCISICS, KatherineAddress:
Waltham, MA, US
Name:
MARSHALL, JohnAddress:
Framingham, MA, US
Name:
CHENG, SengAddress:
Framingham, MA, US
Name:
SCHEULE, RonaldAddress:
Framingham, MA, US
Name:
CABRERA-SALAZAR, MarioAddress:
Framingham, MA, US
Name:
GOOD, AndrewAddress:
Waltham, MA, US
Priority
Number:
201161454034 PDate:
18.3.2011Country:
US
Number:
201261590711 PDate:
25.1.2012Country:
US
Classification
Categories:
A61K 31/439, C07D 453/02, A61K 45/06, A61K 38/47, A61P 3/00, A61P 35/00, A61P 43/00
Annual fees
Number
Paid
Expires
Payer
Number: 9
Paid: 18.2.2020
Expires: 15.3.2021
Payer: Árnason Faktor ehf.